Passage Bio Inc. (PASG) PT Lowered to $24 at Raymond James
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- CVS Health plans to split into two public companies by 2028
- UBS starts bullish coverage on Ferrari Group on luxury logistics growth
- Citi cuts Adobe rating on ’rising risk of a hard reset’
- Apple shares slip amid guidance for tightening margins, slowing services growth
Tweet
Share
E-mailGet Alerts PASG Hot Sheet
Price: $3.40 --0%
Rating Summary:
7 Buy, 7 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 14 | Down: 17 | New: 12
Rating Summary:
7 Buy, 7 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 14 | Down: 17 | New: 12
Join SI Premium – FREE
Raymond James analyst Danielle Brill lowered the price target on Passage Bio Inc. (NASDAQ: PASG) to $24.00 (from $29.00) while maintaining a Outperform rating.
You May Also Be Interested In
- National Stock Exchange of India (NSE:IN) PT Raised to INR1,975 at Macquarie
- Fiserv (FISV) PT Raised to $65 at JPMorgan
- Broadridge Financial (BR) PT Raised to $201 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
